Filing Details
- Accession Number:
- 0001562180-19-004305
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-16 16:04:10
- Reporting Period:
- 2019-08-15
- Accepted Time:
- 2019-08-16 16:04:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597553 | Sage Therapeutics Inc. | SAGE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235598 | M James Frates | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-05-06 | 1,200 | $0.00 | 3,035 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2019-05-06 | 500 | $0.00 | 2,535 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2019-08-15 | 8,000 | $28.35 | 10,535 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-15 | 8,000 | $160.58 | 2,535 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-08-15 | 8,000 | $0.00 | 8,000 | $28.35 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,922 | 2026-06-22 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2014 Stock Option and Incentive Plan and has vested in full on June 22, 2017.
Billionaire Hedge Funds
